Combination Therapy with Valsartan and Chlortalidone

Introduction to Combination Therapy

• The American Heart Association suggests that the combination of an angiotensin II receptor blocker (ARB) like valsartan with a thiazide diuretic like chlortalidone can provide a synergistic antihypertensive effect 3, 4.

Mechanisms of Action and Renal Effects

• Both valsartan and chlortalidone have effects on renal function, but through different mechanisms 1, 2.

Benefits of Combination Therapy

• The combination of valsartan and chlortalidone is available as a fixed-dose formulation (Diovan-HCT) in different concentrations (80/12.5, 160/12.5, 160/25 mg) 4.
• Chlortalidone is preferred over hydrochlorothiazide due to its longer half-life and proven efficacy in reducing cardiovascular events 2, 5.

Risks and Precautions for Renal Function

• The combined use of valsartan and chlortalidone may increase the risk of acute kidney injury, especially in patients with bilateral renal artery stenosis 2, dehydration or volume depletion 4, or pre-existing chronic kidney disease 1.

Monitoring and Recommendations

• The American Journal of Kidney Diseases recommends monitoring renal function and electrolytes within 4 weeks after starting treatment and after each dose increase 5.
• It is suggested to start with low doses in patients with chronic kidney disease and titrate gradually 2, 5.
• Consider temporarily suspending both medications during episodes of diarrhea, vomiting, or decreased oral intake to prevent acute kidney injury 1.

Special Populations

• In patients with advanced chronic kidney disease (eGFR <30 mL/min/1.73 m²), chlortalidone may still be effective in reducing blood pressure 1, 5.
• A small study showed that 24-hour ambulatory blood pressure decreased by 10.5 ± 3.1 mm Hg with chlortalidone 25 mg in patients with a mean eGFR of 26.8 ± 8.8 mL/min/1.73 m² 5.